Search

Your search keyword '"Imai, Hisao"' showing total 8 results
Start Over Author "Imai, Hisao" Journal bmc cancer
8 results on '"Imai, Hisao"'

1. Effects of adding a neurokinin-1 receptor antagonist to 5 mg olanzapine, a 5-hydroxytryptamine-3 receptor antagonist, and dexamethasone for preventing carboplatin-induced nausea and vomiting: a propensity score-matched analysis

Author

Yamamoto, Senri, Iihara, Hirotoshi, Uozumi, Ryuji, Kawazoe, Hitoshi, Tanaka, Kazuki, Fujita, Yukiyoshi, Abe, Masakazu, Imai, Hisao, Karayama, Masato, Hayasaki, Yoh, Hirose, Chiemi, Suda, Takafumi, Nakamura, Kazuto, Suzuki, Akio, Ohno, Yasushi, Morishige, Ken-ichirou, and Inui, Naoki

Published
2022
Full Text
View/download PDF

2. Efficacy and safety of 5 mg olanzapine for nausea and vomiting management in cancer patients receiving carboplatin: integrated study of three prospective multicenter phase II trials

Author

Yamamoto, Senri, Iihara, Hirotoshi, Uozumi, Ryuji, Kawazoe, Hitoshi, Tanaka, Kazuki, Fujita, Yukiyoshi, Abe, Masakazu, Imai, Hisao, Karayama, Masato, Hayasaki, Yoh, Hirose, Chiemi, Suda, Takafumi, Nakamura, Kazuto, Suzuki, Akio, Ohno, Yasushi, Morishige, Ken-ichirou, and Inui, Naoki

Published
2021
Full Text
View/download PDF

3. A randomized phase II study of nutritional and exercise treatment for elderly patients with advanced non-small cell lung or pancreatic cancer: the NEXTAC-TWO study protocol

Author

Miura, Satoru, Naito, Tateaki, Mitsunaga, Shuichi, Omae, Katsuhiro, Mori, Keita, Inano, Toshimi, Yamaguchi, Teiko, Tatematsu, Noriatsu, Okayama, Taro, Morikawa, Ayumu, Mouri, Takako, Tanaka, Hisashi, Kimura, Madoka, Imai, Hisao, Mizukami, Takuro, Imoto, Akira, Kondoh, Chihiro, Shiotsu, Shinsuke, Okuyama, Hiroyuki, Ueno, Makoto, Takahashi, Toshiaki, Tsuji, Tetsuya, Aragane, Hideki, Inui, Akio, Higashiguchi, Takashi, and Takayama, Koichi

Published
2019
Full Text
View/download PDF

4. Unfavorable impact of cancer cachexia on activity of daily living and need for inpatient care in elderly patients with advanced non-small-cell lung cancer in Japan: a prospective longitudinal observational study

Author

Naito, Tateaki, primary, Okayama, Taro, additional, Aoyama, Takashi, additional, Ohashi, Takuya, additional, Masuda, Yoshiyuki, additional, Kimura, Madoka, additional, Shiozaki, Hitomi, additional, Murakami, Haruyasu, additional, Kenmotsu, Hirotsugu, additional, Taira, Tetsuhiko, additional, Ono, Akira, additional, Wakuda, Kazushige, additional, Imai, Hisao, additional, Oyakawa, Takuya, additional, Ishii, Takeshi, additional, Omori, Shota, additional, Nakashima, Kazuhisa, additional, Endo, Masahiro, additional, Omae, Katsuhiro, additional, Mori, Keita, additional, Yamamoto, Nobuyuki, additional, Tanuma, Akira, additional, and Takahashi, Toshiaki, additional

Published
2017
Full Text
View/download PDF

5. Skeletal muscle depletion during chemotherapy has a large impact on physical function in elderly Japanese patients with advanced non–small-cell lung cancer

Author

Naito, Tateaki, primary, Okayama, Taro, additional, Aoyama, Takashi, additional, Ohashi, Takuya, additional, Masuda, Yoshiyuki, additional, Kimura, Madoka, additional, Shiozaki, Hitomi, additional, Murakami, Haruyasu, additional, Kenmotsu, Hirotsugu, additional, Taira, Tetsuhiko, additional, Ono, Akira, additional, Wakuda, Kazushige, additional, Imai, Hisao, additional, Oyakawa, Takuya, additional, Ishii, Takeshi, additional, Omori, Shota, additional, Nakashima, Kazuhisa, additional, Endo, Masahiro, additional, Omae, Katsuhiro, additional, Mori, Keita, additional, Yamamoto, Nobuyuki, additional, Tanuma, Akira, additional, and Takahashi, Toshiaki, additional

Published
2017
Full Text
View/download PDF

6. Prognostic significance of diabetes mellitus in locally advanced non-small cell lung cancer

Author

Imai, Hisao, primary, Kaira, Kyoichi, additional, Mori, Keita, additional, Ono, Akira, additional, Akamatsu, Hiroaki, additional, Matsumoto, Shunichi, additional, Taira, Tetsuhiko, additional, Kenmotsu, Hirotsugu, additional, Harada, Hideyuki, additional, Naito, Tateaki, additional, Murakami, Haruyasu, additional, Endo, Masahiro, additional, Nakajima, Takashi, additional, Yamada, Masanobu, additional, and Takahashi, Toshiaki, additional

Published
2015
Full Text
View/download PDF

7. Progression-free survival at 2 years is a reliable surrogate marker for the 5-year survival rate in patients with locally advanced non-small cell lung cancer treated with chemoradiotherapy

Author

Akamatsu, Hiroaki, primary, Mori, Keita, additional, Naito, Tateaki, additional, Imai, Hisao, additional, Ono, Akira, additional, Shukuya, Takehito, additional, Taira, Tetsuhiko, additional, Kenmotsu, Hirotsugu, additional, Murakami, Haruyasu, additional, Endo, Masahiro, additional, Harada, Hideyuki, additional, Takahashi, Toshiaki, additional, and Yamamoto, Nobuyuki, additional

Published
2014
Full Text
View/download PDF

8. Prognostic significance of diabetes mellitus in locally advanced non-small cell lung cancer.

Author

Hisao Imai, Kyoichi Kaira, Keita Mori, Akira Ono, Hiroaki Akamatsu, Shunichi Matsumoto, Tetsuhiko Taira, Hirotsugu Kenmotsu, Hideyuki Harada, Tateaki Naito, Haruyasu Murakami, Masahiro Endo, Takashi Nakajima, Masanobu Yamada, Toshiaki Takahashi, Imai, Hisao, Kaira, Kyoichi, Mori, Keita, Ono, Akira, and Akamatsu, Hiroaki

Subjects
DIABETES, NON-small-cell lung carcinoma, CANCER radiotherapy, CANCER chemotherapy, LACTATE dehydrogenase, HEMOGLOBINS, PROGNOSIS
Abstract

Background: To investigate the prognostic significance of patient characteristics and clinical laboratory test results in locally advanced non-small cell lung cancer (NSCLC), and in particular the impact of diabetes mellitus (DM) on the survival of patients who underwent chemoradiotherapy.Methods: We retrospectively reviewed 159 patients with locally advanced NSCLC with a focus on DM and other potential prognostic factors, using the log-rank test, and univariate and multivariate analyses to assess their association with survival.Result: Five significant prognostic factors were identified in univariate analysis: stage (p < 0.001), DM (p = 0.04), hemoglobin levels (p = 0.003), serum albumin (p <0.001) and lactate dehydrogenase (LDH) levels (p = 0.01). Furthermore, among the factors tested using Fisher's exact test and the Wilcoxon rank sum test, gender (p = 0.019) and plasma glucose level (p <0.001) were found to have prognostic significance. Multivariate analysis showed that stage, DM, serum albumin and LDH levels were independent prognostic factors for survival (p = 0.007, p = 0.024, p = 0.007 and p = 0.005, respectively).Conclusions: The presence of DM at the time of diagnosis was identified as an independent and significant prognostic factor for predicting negative outcome in locally advanced NSCLC patients. [ABSTRACT FROM AUTHOR]

Published
2015
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results